改良肌锥内义眼台植入术的临床观察

• 作 者: 闫嫒媛
• 机 构: 郑州人民医院眼科,
• 出 处: 中国医疗美容
• 发表日期: 2016年11期
• 关键词: 义眼台植入 上睑下垂 眼窝凹陷 眶内感染 眼球萎缩 术后反应 眼内容物 术后并发症 临床观察 眼球摘除

目的观察改良羟基磷灰石义眼台肌锥内植入术的临床效果。方法采用改良羟基磷灰石义眼台肌锥内植入术治疗各种原因引起的眼球萎缩58例,对手术效果随访观察。结果随访6~18个月,平均8.5个月,本组58例手术全部成功,未发生术后上睑下垂,无义眼台暴露、下沉、脱出、移位及排斥,无眼窝凹陷,无眶内感染,义眼台活动度良好,外形美观,余均取得良好的远期效果。结论改良羟基磷灰石义眼台肌锥内植入术中术后并发症少、手术操作简便、效果稳定持久,术后反应轻、恢复快,值得推广应用于临床。

Objective To observe the clinical effect of modified hydroxyapatite eyelid augmentation implantation. Methods 58 cases of atrophic eyelid atrophy caused by various causes were treated with modified hydroxyapatite eyelid augmentation implantation. The follow-up results were observed. The results were followed up for 6 to 18 months, an average of 8.5 months, the group of 58 cases of surgery were all successful, there was no postoperative ptosis, nonsense eye exposure, sinking, prolapse, displacement and rejection, no sunken socket, no Orbital infection, Yi Yi Taiwan activity is good, beautiful appearance, I have achieved good long-term results. Conclusions The modified hydroxyapatite prosthesis implantation has the advantages of less postoperative complications, simple and convenient operation, stable and long lasting effect, light postoperative reaction and fast recovery. It is worth popularizing in the clinical application.